US$ 22.22
non responder to glp 1 GLP-1 Agonists and the Non-Responder Problem: What We Know, What We Assume, and What Are You a GLP-1 Nonresponder?
Description
About 1 in 8 US adults have taken a GLP-1 medication, and demand continues to grow with up to 35% of Americans expressing interest in using them
Using a projected Target Scan algorithm, miR-27a may target the PPAR gene

No single red flag disqualifies the platform

Dhir, R
10.2337/dc16-0330 [DOI] [PubMed] [Google Scholar] 31
